株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

男性性腺機能低下症の世界市場

Global Market Study on Male Hypogonadism: North America to Remain Largest Market for Male Hypogonadism during 2017 - 2026

発行 Persistence Market Research 商品コード 618910
出版日 ページ情報 英文 170 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.53円で換算しております。
Back to Top
男性性腺機能低下症の世界市場 Global Market Study on Male Hypogonadism: North America to Remain Largest Market for Male Hypogonadism during 2017 - 2026
出版日: 2018年02月12日 ページ情報: 英文 170 Pages
概要

当レポートでは、世界の男性性腺機能低下症市場について調査し、市場の概要、治療法・医薬品タイプ・疾患タイプ・地域別の市場動向、市場規模の推移と予測(過去6年・今後9年間分)、市場シェア、市場成長への各種影響要因、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

第1章 世界経済の見通し

第2章 エグゼクティブサマリー

第3章 市場概要

  • イントロダクション
    • 市場区分
    • 市場定義
  • 市場規模の推移と予測
    • 前年比成長率
  • 市場力学
  • サプライチェーン
  • コスト構造
  • 価格分析
  • PESTEL分析
  • 製品のライフサイクル分析
  • 疫学
  • 流通業者のリスト
  • 参入企業の市場プレゼンス(集中度マップ):地域別

第4章 世界の男性性腺機能低下症市場:セグメント別

  • 市場規模の推移と予測:治療法別
    • テストステロン補充療法
    • ゴナドトロピン補充療法
  • 市場規模の推移と予測:医薬品タイプ
    • 外用ゲル剤
    • 注射剤
    • 経皮パッチ
    • その他
  • 市場規模の推移と予測:疾患タイプ別
    • クラインフェルター症候群
    • 下垂体腺腫
    • カルマン症候群
    • その他

第5章 北米の男性性腺機能低下症市場

第6章 ラテンアメリカの男性性腺機能低下症市場

第7章 欧州の男性性腺機能低下症市場

第8章 日本の男性性腺機能低下症市場

第9章 アジア太平洋(日本を除く)の男性性腺機能低下症市場

第10章 中東・アフリカの男性性腺機能低下症市場

第11章 競合情勢と企業プロファイル

  • 企業の市場シェア
  • 競合情勢
  • 企業プロファイル
    • Endo International Plc
    • Eli Lilly and Company Ltd.
    • AbbVie, Inc.
    • Pfizer, Inc.
    • Merck KGaA
    • Allergan Plc
    • Sun Pharmaceutical Industries Limited
    • Ferring B.V.
  • 重要点

第12章 調査手法

第13章 1次・2次情報源

第14章 前提条件と頭字語

第15章 免責事項

図表

List of Tables

  • TABLE 1 Global Male Hypogonadism Market Value (US$ Mn), 2012-2017
  • TABLE 2 Global Male Hypogonadism Market Value (US$ Mn), 2018-2026
  • TABLE 3 Global Male Hypogonadism Market Value (US$ Mn) and Y-o-Y, 2017-2026
  • TABLE 4 Global Testosterone Replacement Therapy Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 5 Global Testosterone Replacement Therapy Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 6 Global Testosterone Replacement Therapy Segment Market Share, By Region 2012-2017
  • TABLE 7 Global Testosterone Replacement Therapy Segment Market Share, By Region 2018-2026
  • TABLE 8 Global Testosterone Replacement Therapy Segment Y-o-Y, By Region 2017-2026
  • TABLE 9 Global Gonadotropin Replacement Therapy Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 10 Global Gonadotropin Replacement Therapy Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 11 Global Gonadotropin Replacement Therapy Segment Market Share, By Region 2012-2017
  • TABLE 12 Global Gonadotropin Replacement Therapy Segment Market Share, By Region 2018-2026
  • TABLE 13 Global Gonadotropin Replacement Therapy Segment Y-o-Y, By Region 2017-2026
  • TABLE 14 Global Topical Gels Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 15 Global Topical Gels Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 16 Global Topical Gels Segment Market Share, By Region 2012-2017
  • TABLE 17 Global Topical Gels Segment Market Share, By Region 2018-2026
  • TABLE 18 Global Topical Gels Segment Y-o-Y, By Region 2017-2026
  • TABLE 19 Global Injectables Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 20 Global Injectables Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 21 Global Injectables Segment Market Share, By Region 2012-2017
  • TABLE 22 Global Injectables Segment Market Share, By Region 2018-2026
  • TABLE 23 Global Injectables Segment Y-o-Y, By Region 2017-2026
  • TABLE 24 Global Transdermal Patches Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 25 Global Transdermal Patches Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 26 Global Transdermal Patches Segment Market Share, By Region 2012-2017
  • TABLE 27 Global Transdermal Patches Segment Market Share, By Region 2018-2026
  • TABLE 28 Global Transdermal Patches Segment Y-o-Y, By Region 2017-2026
  • TABLE 29 Global Others Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 30 Global Others Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 31 Global Others Segment Market Share, By Region 2012-2017
  • TABLE 32 Global Others Segment Market Share, By Region 2018-2026
  • TABLE 33 Global Others Segment Y-o-Y, By Region 2017-2026
  • TABLE 34 Global Klinefelter's Syndrome Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 35 Global Klinefelter's Syndrome Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 36 Global Klinefelter's Syndrome Segment Market Share, By Region 2012-2017
  • TABLE 37 Global Klinefelter's Syndrome Segment Market Share, By Region 2018-2026
  • TABLE 38 Global Klinefelter's Syndrome Segment Y-o-Y, By Region 2017-2026
  • TABLE 39 Global Pituitary Adenomas Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 40 Global Pituitary Adenomas Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 41 Global Pituitary Adenomas Segment Market Share, By Region 2012-2017
  • TABLE 42 Global Pituitary Adenomas Segment Market Share, By Region 2018-2026
  • TABLE 43 Global Pituitary Adenomas Segment Y-o-Y, By Region 2017-2026
  • TABLE 44 Global Kallmann Syndrome Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 45 Global Kallmann Syndrome Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 46 Global Kallmann Syndrome Segment Market Share, By Region 2012-2017
  • TABLE 47 Global Kallmann Syndrome Segment Market Share, By Region 2018-2026
  • TABLE 48 Global Kallmann Syndrome Segment Y-o-Y, By Region 2017-2026
  • TABLE 49 Global Other Types Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 50 Global Other Types Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 51 Global Other Types Segment Market Share, By Region 2012-2017
  • TABLE 52 Global Other Types Segment Market Share, By Region 2018-2026
  • TABLE 53 Global Other Types Segment Y-o-Y, By Region 2017-2026
  • TABLE 54 North America Current Expenditure on Health, (% of GDP), by Country, 2010 - 2016
  • TABLE 55 North America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
  • TABLE 56 North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
  • TABLE 57 North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
  • TABLE 58 North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
  • TABLE 59 North America Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017
  • TABLE 60 North America Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026
  • TABLE 61 North America Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017
  • TABLE 62 North America Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026
  • TABLE 63 North America Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017
  • TABLE 64 North America Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026
  • TABLE 65 North America Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017
  • TABLE 66 North America Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026
  • TABLE 67 Latin America Current Expenditure on Health, (% of GDP), by Country, 2010 - 2016
  • TABLE 68 Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
  • TABLE 69 Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
  • TABLE 70 Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
  • TABLE 71 Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
  • TABLE 72 Latin America Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017
  • TABLE 73 Latin America Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026
  • TABLE 74 Latin America Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017
  • TABLE 75 Latin America Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026
  • TABLE 76 Latin America Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017
  • TABLE 77 Latin America Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026
  • TABLE 78 Latin America Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017
  • TABLE 79 Latin America Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026
  • TABLE 80 Europe Current Expenditure on Health, (% of GDP), by Country, 2010 - 2016
  • TABLE 81 Europe Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
  • TABLE 82 Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
  • TABLE 83 Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
  • TABLE 84 Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
  • TABLE 85 Europe Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017
  • TABLE 86 Europe Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026
  • TABLE 87 Europe Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017
  • TABLE 88 Europe Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026
  • TABLE 89 Europe Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017
  • TABLE 90 Europe Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026
  • TABLE 91 Europe Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017
  • TABLE 92 Europe Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026
  • TABLE 93 Japan Current Expenditure on Health, (% of GDP), by Country, 2010 - 2016
  • TABLE 94 Japan Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
  • TABLE 95 Japan Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
  • TABLE 96 Japan Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
  • TABLE 97 Japan Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
  • TABLE 98 Japan Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017
  • TABLE 99 Japan Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026
  • TABLE 100 Japan Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017
  • TABLE 101 Japan Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026
  • TABLE 102 Japan Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017
  • TABLE 103 Japan Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026
  • TABLE 104 Japan Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017
  • TABLE 105 Japan Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026
  • TABLE 106 APEJ Current Expenditure on Health, (% of GDP), by Country, 2010 - 2016
  • TABLE 107 APEJ Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
  • TABLE 108 APEJ Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
  • TABLE 109 APEJ Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
  • TABLE 110 APEJ Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
  • TABLE 111 APEJ Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017
  • TABLE 112 APEJ Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026
  • TABLE 113 APEJ Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017
  • TABLE 114 APEJ Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026
  • TABLE 115 APEJ Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017
  • TABLE 116 APEJ Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026
  • TABLE 117 APEJ Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017
  • TABLE 118 APEJ Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026
  • TABLE 119 MEA Current Expenditure on Health, (% of GDP), by Country, 2010 - 2016
  • TABLE 120 MEA Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
  • TABLE 121 MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
  • TABLE 122 MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
  • TABLE 123 MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
  • TABLE 124 MEA Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017
  • TABLE 125 MEA Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026
  • TABLE 126 MEA Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017
  • TABLE 127 MEA Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026
  • TABLE 128 MEA Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017
  • TABLE 129 MEA Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026
  • TABLE 130 MEA Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017
  • TABLE 131 MEA Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026

List of Figures

  • FIG. 1 Global Male Hypogonadism Market Value (US$ Mn), 2012-2017
  • FIG. 2 Global Male Hypogonadism Market Value (US$ Mn) Forecast, 2018-2026
  • FIG. 3 Global Male Hypogonadism Market Value (US$ Mn) and Y-o-Y, 2017-2026
  • FIG. 4 Global Testosterone Replacement Therapy Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 5 Global Testosterone Replacement Therapy Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 6 Global Testosterone Replacement Therapy Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 7 Global Gonadotropin Replacement Therapy Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 8 Global Gonadotropin Replacement Therapy Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 9 Global Gonadotropin Replacement Therapy Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 10 Global Topical Gels Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 11 Global Topical Gels Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 12 Global Topical Gels Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 13 Global Injectables Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 14 Global Injectables Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 15 Global Injectables Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 16 Global Transdermal Patches Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 17 Global Transdermal Patches Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 18 Global Transdermal Patches Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 19 Global Others Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 20 Global Others Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 21 Global Others Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 22 Global Klinefelter's Syndrome Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 23 Global Klinefelter's Syndrome Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 24 Global Klinefelter's Syndrome Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 25 Global Pituitary Adenomas Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 26 Global Pituitary Adenomas Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 27 Global Pituitary Adenomas Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 28 Global Kallmann Syndrome Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 29 Global Kallmann Syndrome Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 30 Global Kallmann Syndrome Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 31 Global Other Types Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 32 Global Other Types Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 33 Global Other Types Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 34 North America Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017
  • FIG. 35 North America Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026
  • FIG. 36 North America Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017
  • FIG. 37 North America Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026
  • FIG. 38 North America Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017
  • FIG. 39 North America Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026
  • FIG. 40 North America Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017
  • FIG. 41 North America Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026
  • FIG. 42 Latin America Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017
  • FIG. 43 Latin America Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026
  • FIG. 44 Latin America Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017
  • FIG. 45 Latin America Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026
  • FIG. 46 Latin America Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017
  • FIG. 47 Latin America Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026
  • FIG. 48 Latin America Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017
  • FIG. 49 Latin America Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026
  • FIG. 50 Europe Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017
  • FIG. 51 Europe Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026
  • FIG. 52 Europe Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017
  • FIG. 53 Europe Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026
  • FIG. 54 Europe Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017
  • FIG. 55 Europe Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026
  • FIG. 56 Europe Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017
  • FIG. 57 Europe Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026
  • FIG. 58 Japan Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017
  • FIG. 59 Japan Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026
  • FIG. 60 Japan Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017
  • FIG. 61 Japan Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026
  • FIG. 62 Japan Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017
  • FIG. 63 Japan Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026
  • FIG. 64 Japan Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017
  • FIG. 65 Japan Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026
  • FIG. 66 APEJ Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017
  • FIG. 67 APEJ Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026
  • FIG. 68 APEJ Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017
  • FIG. 69 APEJ Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026
  • FIG. 70 APEJ Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017
  • FIG. 71 APEJ Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026
  • FIG. 72 APEJ Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017
  • FIG. 73 APEJ Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026
  • FIG. 74 MEA Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017
  • FIG. 75 MEA Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026
  • FIG. 76 MEA Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017
  • FIG. 77 MEA Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026
  • FIG. 78 MEA Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017
  • FIG. 79 MEA Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026
  • FIG. 80 MEA Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017
  • FIG. 81 MEA Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026
目次

Male hypogonadism is a condition in males wherein the testes depict a significantly reduced functioning level than normal. Reduction in rate of biosynthesis of the male sex hormones consequently results into male hypogonadism, which can vary in terms of severity among individuals. Partial or complete infertility are among major end-results entailing male hypogonadism, which in turn have created the need for effective treatment. Persistence Market Research has published a new comprehensive research report titled, "Male Hypogonadism Market: Global Industry Analysis (2012-2016) and Forecast (2017-2026)". The report covers present market scenario as well as imparts future growth prospects of the male hypogonadism market for the period between 2017 and 2026. The report also engulfs key drivers, hindrances, opportunities and trends that are affecting expansion of the global male hypogonadism market. The report offers an overall picture of the global male hypogonadism market, in order to help businesses seeking opportunities for making investments in the market.

Structure of the Report

The report provides an exhaustive synopsis of the global male hypogonadism market, engulfing an executive summary that elucidates the core trends influencing the market expansion. This chapter also sheds light on impacts that the dynamics are likely to pose on growth of the market in the long run. The report also imparts figures appertaining to CAGRs from a historical and forecast point of view. An overview of the global male hypogonadism market follows the executive summary, and issues a clear picture of the market's scope to the report readers. The overview includes a concise market introduction succeeded by a formal definition of "male hypogonadism". Chapters subsequent to the overview elaborates several dynamics including driving factors, limitations and prospects being observed in the market through the forecast period. Meanwhile these chapter also inundate detailed insights related to the bottom line of enterprises, global economy and fiscal stimulus.Competition Landscape

This analytical research report on the global male hypogonadism market is a complete package, which includes intelligence on key participants underpinning the market expansion. In the last chapter of the report, which elucidates the competitive scenario of the market, strategies implemented by the market players, along with their product overview, company overview, key financials, key developments and SWOT analysis has been rendered exhaustively. In addition, region-wide spread of these market players, their future expansion plans, market shares, revenues, and mergers & acquisition activities between them have been described in detail in this concluding chapter of the report. An intensity map has been employed in the report to profile the market players situated across geographies.

Research Methodology

Credibility of the researched statistics and data is backed by the unique research methodology employed by the analysts at PMR, which ensures higher accuracy. PMR's research report on the global male hypogonadism market can assist its readers in gaining detailed insights on many different aspects governing the market around key regional segments included in the report. The report readers can further slate key strategies for tapping into vital revenue pockets and gaining benefits over the intensifying competition in the market. Information presented in the report has been scrutinized and monitored thoroughly by PMR's industry experts. Figures and numbers offered in the report have also been validated by the analysts in order to facilitate strategic decision making for the report readers.

Table of Contents

1. Global Economic Outlook

2. Global Male Hypogonadism Market - Executive Summary

  • 2.1. Opportunity Analysis - Male Hypogonadism Market

3. Global Male Hypogonadism Market Overview

  • 3.1. Introduction
    • 3.1.1. Global Male Hypogonadism Market Taxonomy
    • 3.1.2. Global Male Hypogonadism Market Definition
  • 3.2. Global Male Hypogonadism Market Size (US$ Mn) and Forecast, 2012-2026
    • 3.2.1. Global Male Hypogonadism Market Y-o-Y Growth
  • 3.3. Global Male Hypogonadism Market Dynamics
  • 3.4. Supply Chain
  • 3.5. Cost Structure
  • 3.6. Pricing Analysis
  • 3.7. PESTL Analysis
  • 3.8. Product Life Cycle Analysis
  • 3.9. Epidemiology
  • 3.10. List of Distributors
  • 3.11. Key Participants Market Presence (Intensity Map) By Region

4. Global Male Hypogonadism Market Analysis and Forecast 2012-2026

  • 4.1. Global Male Hypogonadism Market Size and Forecast By Therapy , 2012-2026
    • 4.1.1. Testosterone Replacement Therapy Market Size and Forecast, 2012-2026
      • 4.1.1.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.1.2. Market Share Comparison, By Region
      • 4.1.1.3. Y-o-Y growth Comparison, By Region
    • 4.1.2. Gonadotropin Replacement Therapy Market Size and Forecast, 2012-2026
      • 4.1.2.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.2.2. Market Share Comparison, By Region
      • 4.1.2.3. Y-o-Y growth Comparison, By Region
  • 4.2. Global Male Hypogonadism Market Size and Forecast By Drug Type, 2012-2026
    • 4.2.1. Topical Gels Market Size and Forecast, 2012-2026
      • 4.2.1.1. Revenue (US$ Mn) Comparison, By Region
      • 4.2.1.2. Market Share Comparison, By Region
      • 4.2.1.3. Y-o-Y growth Comparison, By Region
    • 4.2.2. Injectables Market Size and Forecast, 2012-2026
      • 4.2.2.1. Revenue (US$ Mn) Comparison, By Region
      • 4.2.2.2. Market Share Comparison, By Region
      • 4.2.2.3. Y-o-Y growth Comparison, By Region
    • 4.2.3. Transdermal Patches Market Size and Forecast, 2012-2026
      • 4.2.3.1. Revenue (US$ Mn) Comparison, By Region
      • 4.2.3.2. Market Share Comparison, By Region
      • 4.2.3.3. Y-o-Y growth Comparison, By Region
    • 4.2.4. Others Market Size and Forecast, 2012-2026
      • 4.2.4.1. Revenue (US$ Mn) Comparison, By Region
      • 4.2.4.2. Market Share Comparison, By Region
      • 4.2.4.3. Y-o-Y growth Comparison, By Region
  • 4.3. Global Male Hypogonadism Market Size and Forecast By Disease Type, 2012-2026
    • 4.3.1. Klinefelter's Syndrome Market Size and Forecast, 2012-2026
      • 4.3.1.1. Revenue (US$ Mn) Comparison, By Region
      • 4.3.1.2. Market Share Comparison, By Region
      • 4.3.1.3. Y-o-Y growth Comparison, By Region
    • 4.3.2. Pituitary Adenomas Market Size and Forecast, 2012-2026
      • 4.3.2.1. Revenue (US$ Mn) Comparison, By Region
      • 4.3.2.2. Market Share Comparison, By Region
      • 4.3.2.3. Y-o-Y growth Comparison, By Region
    • 4.3.3. Kallmann Syndrome Market Size and Forecast, 2012-2026
      • 4.3.3.1. Revenue (US$ Mn) Comparison, By Region
      • 4.3.3.2. Market Share Comparison, By Region
      • 4.3.3.3. Y-o-Y growth Comparison, By Region
    • 4.3.4. Other Types Market Size and Forecast, 2012-2026
      • 4.3.4.1. Revenue (US$ Mn) Comparison, By Region
      • 4.3.4.2. Market Share Comparison, By Region
      • 4.3.4.3. Y-o-Y growth Comparison, By Region

5. North America Male Hypogonadism Market Size and Forecast, 2012-2026

  • 5.1. North America Outlook
  • 5.2. North America Parent Market Outlook
  • 5.3. North America Target Market Outlook
  • 5.4. Revenue (US$ Mn) Comparison, By Country
    • 5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026
    • 5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026
  • 5.5. Revenue (US$ Mn) Comparison, By Therapy
  • 5.6. Revenue (US$ Mn) Comparison, By Drug Type
  • 5.7. Revenue (US$ Mn) Comparison, By Disease Type

6. Latin America Male Hypogonadism Market Size and Forecast, 2012-2026

  • 6.1. Latin America Outlook
  • 6.2. Latin America Parent Market Outlook
  • 6.3. Latin America Target Market Outlook
  • 6.4. Revenue (US$ Mn) Comparison, By Country
    • 6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026
    • 6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026
    • 6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026
  • 6.5. Revenue (US$ Mn) Comparison, By Therapy
  • 6.6. Revenue (US$ Mn) Comparison, By Drug Type
  • 6.7. Revenue (US$ Mn) Comparison, By Disease Type

7. Europe Male Hypogonadism Market Size and Forecast, 2012-2026

  • 7.1. Europe Outlook
  • 7.2. Europe Parent Market Outlook
  • 7.3. Europe Target Market Outlook
  • 7.4. Revenue (US$ Mn) Comparison, By Country
    • 7.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026
    • 7.4.2. UK Market Size and Forecast (US$ Mn), 2012-2026
    • 7.4.3. France Market Size and Forecast (US$ Mn), 2012-2026
    • 7.4.4. Spain Market Size and Forecast (US$ Mn), 2012-2026
    • 7.4.5. Italy Market Size and Forecast (US$ Mn), 2012-2026
    • 7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2012-2026
  • 7.5. Revenue (US$ Mn) Comparison, By Therapy
  • 7.6. Revenue (US$ Mn) Comparison, By Drug Type
  • 7.7. Revenue (US$ Mn) Comparison, By Disease Type

8. Japan Male Hypogonadism Market Size and Forecast, 2012-2026

  • 8.1. Japan Outlook
  • 8.2. Japan Parent Market Outlook
  • 8.3. Japan Target Market Outlook
  • 8.4. Revenue (US$ Mn), 2012-2026
    • 8.4.1. Japan Market Size and Forecast (US$ Mn), 2012-2026
  • 8.5. Revenue (US$ Mn) Comparison, By Therapy
  • 8.6. Revenue (US$ Mn) Comparison, By Drug Type
  • 8.7. Revenue (US$ Mn) Comparison, By Disease Type

9. APEJ Male Hypogonadism Market Size and Forecast, 2012-2026

  • 9.1. APEJ Outlook
  • 9.2. APEJ Parent Market Outlook
  • 9.3. APEJ Target Market Outlook
  • 9.4. Revenue (US$ Mn) Comparison, By Country
    • 9.4.1. China Market Size and Forecast (US$ Mn), 2012-2026
    • 9.4.2. India Market Size and Forecast (US$ Mn), 2012-2026
    • 9.4.3. Thailand Market Size and Forecast (US$ Mn), 2012-2026
    • 9.4.4. Singapore Market Size and Forecast (US$ Mn), 2012-2026
    • 9.4.5. Australia Market Size and Forecast (US$ Mn), 2012-2026
    • 9.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2012-2026
  • 9.5. Revenue (US$ Mn) Comparison, By Therapy
  • 9.6. Revenue (US$ Mn) Comparison, By Drug Type
  • 9.7. Revenue (US$ Mn) Comparison, By Disease Type

10. MEA Male Hypogonadism Market Size and Forecast, 2012-2026

  • 10.1. MEA Outlook
  • 10.2. MEA Parent Market Outlook
  • 10.3. MEA Target Market Outlook
  • 10.4. Revenue (US$ Mn) Comparison, By Country
    • 10.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026
    • 10.4.2. South Africa Market Size and Forecast (US$ Mn), 2012-2026
    • 10.4.3. Israel Market Size and Forecast (US$ Mn), 2012-2026
    • 10.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026
  • 10.5. Revenue (US$ Mn) Comparison, By Therapy
  • 10.6. Revenue (US$ Mn) Comparison, By Drug Type
  • 10.7. Revenue (US$ Mn) Comparison, By Disease Type

11. Global Male Hypogonadism Market Company Share, Competition Landscape and Company Profiles

  • 11.1. Company Share Analysis
  • 11.2. Competition Landscape
  • 11.3. Company Profiles
    • 11.3.1. Endo International Plc
    • 11.3.2. Eli Lilly and Company Ltd.
    • 11.3.3. AbbVie, Inc.
    • 11.3.4. Pfizer, Inc.
    • 11.3.5. Merck KGaA
    • 11.3.6. Allergan Plc
    • 11.3.7. Sun Pharmaceutical Industries Limited
    • 11.3.8. Ferring B.V.
  • 11.4. Key takeaways - Male Hypogonadism Market

12. Research Methodology

13. Secondary and Primary Sources

14. Assumptions and Acronyms

15. Disclaimer

Back to Top